4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000004
Chairperson & CEO sold 9,500 shares at an average $489.91 ($4,654,129)
- Chairperson & CEO sold 9,500 shares at $146.03 ($1,387,285)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-04 | Sale : show line 1 in the form 10b5-1 | +9,500 | $146.03 | $1,387,285 | 9,630 | D |
| 2026-03-04 | Sale : show line 2 in the form 10b5-1 | −399 | $486.42 | $194,083 | 9,231 | D |
| 2026-03-04 | Sale : show line 3 in the form 10b5-1 | −926 | $487.55 | $451,475 | 8,305 | D |
| 2026-03-04 | Sale : show line 4 in the form 10b5-1 | −2,429 | $488.63 | $1,186,882 | 5,876 | D |
| 2026-03-04 | Sale : show line 5 in the form 10b5-1 | −2,290 | $489.68 | $1,121,367 | 3,586 | D |
| 2026-03-04 | Sale : show line 6 in the form 10b5-1 | −1,808 | $490.52 | $886,858 | 1,778 | D |
| 2026-03-04 | Sale : show line 7 in the form 10b5-1 | −485 | $491.33 | $238,296 | 1,293 | D |
| 2026-03-04 | Sale : show line 8 in the form 10b5-1 | −243 | $492.44 | $119,663 | 1,050 | D |
| Open-market sales · 19,000 sh · avg $317.97 · $6,041,414 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-04 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Options | −9,500 | 211,500 | D |
Loading xslF345X05/primarydocument.xml…